New substances for prostate cancer

In recent years, there has been great progress in the treatment of metastatic prostate cancer. The aim of this project, undertaken on behalf of Janssen-Cilag and in collaboration with opinion leaders in the field of urology, was to prepare a review covering new studies in this indication, with a special focus on testosterone.

Effect:

The article appeared in the prestigious Springer journal »Der Urologe« and made an important contribution to the understanding of new substances in the treatment of prostate cancer.